RETRANSMISSION: NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025
NanoViricides(US:NNVC) Accessnewswireยท2025-09-11 12:30Core Insights - NanoViricides, Inc. is a clinical stage company focused on developing broad-spectrum antiviral drugs that are designed to be effective against viruses [1] Company Announcement - The company will present at the Life Science Executive Partnering (LSX) World Congress 2025 in Boston, MA on September 17th at 12:30pm [1]